Researchers identify anti-inflammatory prodrug Minnelide with potential against SARS-CoV-2

By | May 10, 2021
Using a transgenic mouse model of COVID-19, they have observed that treatment with Minnelide reduces viral load and inflammation in the lungs and improves survival. The study is currently available on the bioRxiv* preprint server.